BuGZ binds to the <i>cat-3</i> gene region specifically and its recruitment responses to <i>cat-3</i> overexpression caused by oxidative stress. by Yike Zhou (12800411)

Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study by Aurélie Chabanon (5562944)

Percentage of live hard coral cover in 2008 and 2018 at the study site, Lizard Island, on the Great Barrier Reef. by Víctor Huertas (4780728)

Data_Sheet_1_Independent effect of body mass index variation on amyloid-β positivity.docx by Sung Hoon Kang (2258038)

“…</p>Methods<p>We retrospectively recruited 1,035 non-demented participants ≥50 years of age who underwent Aβ PET and had at least three BMI measurements in the memory clinic at Samsung Medical Center. …”

Temporal variation of frequency peaks during seizure onset; black solid line shows the ∼ 18 Hz peak; gray dashed line shows the ∼ 10 Hz peak with parameters from Table 1. by F. Deeba (8661837)

NADPH oxidation and H₂O₂ production by Bs3 and Bs3_S211A. by Christina Krönauer (11301989)

“…NADPH oxidation was monitored via decrease of absorbance at 340 nm. Yucasin and methimazole (MMI) were dissolved in DMSO and added at a final concentration of 50 μM. …”

The deletion of <i>TgCRT</i> altered microneme secretion, without affecting the microneme steady abundance, intracellular trafficking, or intramembrane cleavage on the parasite sur... by L. Brock Thornton (6808385)

TGF-β signaling modulates miR-181a/b action in the assembly of retinal circuitry. by Sabrina Carrella (404731)

“…Treatment of control-MOs embryos with 80μM SB432542 (m) phenocopied the miR-181a/b-morphant optic nerve length decrease (l). Addition of TGF-β for 24 h (from St30 to St32) to miR-181a/b morphants (n) was sufficient to rescue correct optic nerve growth in Ath5:eGFP morphant embryos. …”

Apparent Forel-Ule colours with regular and deficient colour vision. by Olivier Burggraaff (10668301)

S1 Dataset - by Devon England (21262225)

“…Surgical complications included a high incidence of laryngeal hemiplegia. Comparison of operated to non-operated sites within individuals radiographed years later showed consistent, mildly reduced APJ opacity at most operated sites without a consistent decrease in APJ height or area ratios. …”

S7 Dataset - by Devon England (21262225)

“…Surgical complications included a high incidence of laryngeal hemiplegia. Comparison of operated to non-operated sites within individuals radiographed years later showed consistent, mildly reduced APJ opacity at most operated sites without a consistent decrease in APJ height or area ratios. …”

S8 Dataset - by Devon England (21262225)

“…Surgical complications included a high incidence of laryngeal hemiplegia. Comparison of operated to non-operated sites within individuals radiographed years later showed consistent, mildly reduced APJ opacity at most operated sites without a consistent decrease in APJ height or area ratios. …”

S3 Dataset - by Devon England (21262225)

“…Surgical complications included a high incidence of laryngeal hemiplegia. Comparison of operated to non-operated sites within individuals radiographed years later showed consistent, mildly reduced APJ opacity at most operated sites without a consistent decrease in APJ height or area ratios. …”

S4 Dataset - by Devon England (21262225)

“…Surgical complications included a high incidence of laryngeal hemiplegia. Comparison of operated to non-operated sites within individuals radiographed years later showed consistent, mildly reduced APJ opacity at most operated sites without a consistent decrease in APJ height or area ratios. …”

S6 Dataset - by Devon England (21262225)

“…Surgical complications included a high incidence of laryngeal hemiplegia. Comparison of operated to non-operated sites within individuals radiographed years later showed consistent, mildly reduced APJ opacity at most operated sites without a consistent decrease in APJ height or area ratios. …”

S2 Dataset - by Devon England (21262225)

“…Surgical complications included a high incidence of laryngeal hemiplegia. Comparison of operated to non-operated sites within individuals radiographed years later showed consistent, mildly reduced APJ opacity at most operated sites without a consistent decrease in APJ height or area ratios. …”

S5 Dataset - by Devon England (21262225)

“…Surgical complications included a high incidence of laryngeal hemiplegia. Comparison of operated to non-operated sites within individuals radiographed years later showed consistent, mildly reduced APJ opacity at most operated sites without a consistent decrease in APJ height or area ratios. …”

Measuring results of Hela cells subjected to different durations of fluid shear stress by Atomic Force Microscopy (AFM) by Xinyao Zhao (5824427)

METTL3 and ALKBH5 oppositely regulate m⁶A modification of <i>TFEB</i> mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes by Huiwen Song (755791)

“…</p> <p>ACTB, actin beta; ALKBH5, alkB homolog 5, RNA demethylase; ANXA5, annexin A5; ATG, autophagy-related; BafA, bafilomycin A₁; CASP3, caspase 3; ELAVL1, ELAV like RNA binding protein 1; FTO, FTO, alpha-ketoglutarate dependent dioxygenase; GFP, green fluorescent protein; GST, glutathione S-transferase; HNRNPD, heterogeneous nuclear ribonucleoprotein D; H/R, hypoxia/reoxygenation; I/R, ischemia/reperfusion; LAD, left anterior descending; m⁶A, N⁶-methyladenosine; MEFs, mouse embryo fibroblasts; Mer, mutated estrogen receptor domains; METTL3, methyltransferase like 3; METTL14, methyltransferase like 14; mRFP, monomeric red fluorescent protein; MTORC1, mechanistic target of rapamycin kinase complex 1; NMVCs, neonatal mouse ventricular cardiomyocytes; PCNA, proliferating cell nuclear antigen; PE, phosphatidylethanolamine; PI, propidium iodide; PTMs, post-translational modifications; PVDF, polyvinylidenedifluoride; RIP, RNA-immunoprecipitation; siRNA, small interfering RNA; SQSTM1, sequestosome 1; TFEB, transcription factor EB; TUBA: tublin alpha; WTAP, WT1 associated protein; YTHDF, YTH N6-methyladenosine RNA binding protein</p>…”

Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions by Paz Sobrino-Vegas (680195)

“…HCV seroconversion rates decreased from 1.77 to 0.65 (aIRR = 0.37; 95%CI: 0.12–1.11); in MSM from 1.06 to 0.49 (aIRR = 0.46; 95%CI: 0.09–2.31); in HTX from 2.55 to 0.59 (aIRR = 0.23; 95%CI: 0.06–0.98). …”